Recruiting Paroxysmal Nocturnal Hemoglobinuria Studies in Atlanta
About Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Atlanta
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disease where the immune system destroys red blood cells, causing dark-colored urine, fatigue, and blood clots. It is caused by a genetic mutation in blood stem cells. Treatment includes complement inhibitors like eculizumab.
There are currently 2 paroxysmal nocturnal hemoglobinuria clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 24 participants. Research is being sponsored by Apellis Pharmaceuticals, Inc., Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Paroxysmal Nocturnal Hemoglobinuria Clinical Trials in Atlanta — FAQ
Are there paroxysmal nocturnal hemoglobinuria clinical trials in Atlanta?
Yes, there are 2 paroxysmal nocturnal hemoglobinuria clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Atlanta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.
Are clinical trials in Atlanta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.
What paroxysmal nocturnal hemoglobinuria treatments are being tested?
The 2 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for paroxysmal nocturnal hemoglobinuria.
Data updated October 14, 2026 from ClinicalTrials.gov